CA1034124A - Procede de fabrication de nouvelles quinoleines - Google Patents

Procede de fabrication de nouvelles quinoleines

Info

Publication number
CA1034124A
CA1034124A CA198,654A CA198654A CA1034124A CA 1034124 A CA1034124 A CA 1034124A CA 198654 A CA198654 A CA 198654A CA 1034124 A CA1034124 A CA 1034124A
Authority
CA
Canada
Prior art keywords
manufacture
quinolines
new
new quinolines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA198,654A
Other languages
English (en)
Other versions
CA198654S (en
Inventor
Pier G. Ferrini
Georges Haas
Alberto Rossi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH672273A external-priority patent/CH578534A5/de
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of CA1034124A publication Critical patent/CA1034124A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA198,654A 1973-05-11 1974-05-01 Procede de fabrication de nouvelles quinoleines Expired CA1034124A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH672273A CH578534A5 (en) 1973-05-11 1973-05-11 Quinoline-3-carboxylic acid derivs - with e.g. analgesic, antinociceptive, antiinflammatory and antiallergic props
CH393574 1974-03-21

Publications (1)

Publication Number Publication Date
CA1034124A true CA1034124A (fr) 1978-07-04

Family

ID=25694221

Family Applications (1)

Application Number Title Priority Date Filing Date
CA198,654A Expired CA1034124A (fr) 1973-05-11 1974-05-01 Procede de fabrication de nouvelles quinoleines

Country Status (9)

Country Link
US (1) US3960868A (fr)
JP (1) JPS5018480A (fr)
AT (1) AT332406B (fr)
AU (1) AU6877174A (fr)
CA (1) CA1034124A (fr)
DE (1) DE2421121A1 (fr)
FR (1) FR2228488B1 (fr)
GB (1) GB1467061A (fr)
NL (1) NL7405910A (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190659A (en) 1973-08-27 1980-02-26 Sandoz, Inc. Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters
US4273930A (en) * 1977-06-20 1981-06-16 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acid esters
US4187309A (en) * 1977-06-20 1980-02-05 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4281131A (en) * 1977-06-20 1981-07-28 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4128649A (en) * 1977-06-29 1978-12-05 Sandoz, Inc. 4-Hydroxy-pyrido[2,3-b]pyridine-2(1H)-one-3-carboxylic acids and esters
US4119720A (en) * 1977-07-06 1978-10-10 Sandoz, Inc. Unsaturated esters of 4-hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
US4169893A (en) * 1978-03-13 1979-10-02 Sandoz, Inc. 4-hydroxy-naphthpyridine-2(1h)-one-3-carboxylic acids and esters
FR2482596A1 (fr) * 1980-05-19 1981-11-20 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
US4463058A (en) * 1981-06-16 1984-07-31 Atlantic Richfield Company Silicon carbide whisker composites
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
JPS58105965A (ja) * 1981-12-15 1983-06-24 Nippon Shinyaku Co Ltd 置換キノリンカルボン酸誘導体
JPS58219166A (ja) * 1982-06-14 1983-12-20 Nippon Shinyaku Co Ltd ４−キノロン誘導体
DE3430800A1 (de) * 1984-08-22 1986-03-06 Bayer Ag, 5090 Leverkusen Anzinpigmente
DE3571974D1 (en) * 1984-12-06 1989-09-07 Pfizer Substituted dihydroquinolone carboxylic acids, anti-bacterial compositions containing them
US4929613A (en) * 1987-08-26 1990-05-29 Warner-Lambert Company Antibacterial agents
DE3811341A1 (de) * 1987-10-09 1989-04-27 Bayer Ag In 7-stellung c-verknuepfte chinolon- und 1,8-naphthyridin-4-on-carbonsaeure und ein verfahren zu ihrer herstellung
US5039682A (en) * 1988-06-21 1991-08-13 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US5104868A (en) * 1988-06-21 1992-04-14 Pfizer Inc. Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters
US5233091A (en) * 1988-06-21 1993-08-03 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US5103040A (en) * 1988-06-21 1992-04-07 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
AU5449590A (en) * 1989-04-28 1990-11-29 Daiichi Pharmaceutical Co., Ltd. Anti-hiv drug
US5310913A (en) * 1989-06-09 1994-05-10 Kabi Pharmacia Aktiebolag Derivatives of quinoline-3-carboxanilide
US4992449A (en) * 1990-02-01 1991-02-12 American Cyanamid Company 7-(substituted)cycloalkylamino-1-(substituted)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
US5412104A (en) * 1990-09-07 1995-05-02 Schering Corporation Ester and alkoxy substituted benzopyrans
EP0550464A1 (fr) * 1990-09-07 1993-07-14 Schering Corporation Composes anti-viraux et composes anti-hypertenseurs
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
DE4138820A1 (de) * 1991-11-26 1993-05-27 Basf Ag Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
SE9201076L (sv) * 1992-04-06 1993-10-07 Shimon Slavin Användningen av gamla läkemedel för behandling av diabetes
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
ATE303993T1 (de) * 1997-12-22 2005-09-15 Pharmacia & Upjohn Co Llc 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
US6248739B1 (en) * 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
CA2659605A1 (fr) * 2006-07-26 2008-01-31 Novartis Ag Inhibiteurs de l'undecaprenyl pyrophosphate synthase
BR112013007850A2 (pt) 2010-10-14 2016-06-07 Immunahr Ab 1,2-diidro-4-hidróxi-2-oxo-quinolina-3-carboxanilidas como ativadores de ahr

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB830832A (en) * 1957-02-15 1960-03-23 Ici Ltd New quinolones and therapeutic compositions containing them
US3452026A (en) * 1966-03-15 1969-06-24 Bristol Myers Co Substituted 1,2,3,4-tetrahydroquinolines
US3542851A (en) * 1966-07-01 1970-11-24 Merck & Co Inc Novel acrylate,amines and ethers
US3761592A (en) * 1969-03-18 1973-09-25 R Mizzoni Quinoline derivatives exhibiting growth promoting and anticoccidial effects
US3506667A (en) * 1969-05-01 1970-04-14 Warner Lambert Pharmaceutical Furo quinoline carboxylates
BE759357A (fr) * 1969-11-24 1971-04-30 Sumitomo Chemical Co Derives de 4-thioxoquinoleine
NL7101049A (fr) * 1970-01-28 1971-07-30

Also Published As

Publication number Publication date
NL7405910A (fr) 1974-11-13
GB1467061A (en) 1977-03-16
DE2421121A1 (de) 1975-01-16
AT332406B (de) 1976-09-27
JPS5018480A (fr) 1975-02-26
US3960868A (en) 1976-06-01
ATA387574A (de) 1976-01-15
FR2228488B1 (fr) 1977-05-06
AU6877174A (en) 1975-11-13
FR2228488A1 (fr) 1974-12-06

Similar Documents

Publication Publication Date Title
CA1034124A (fr) Procede de fabrication de nouvelles quinoleines
CA1029035A (fr) Procede de fabrication de l'hexamethyltetraline
CA1030556A (fr) Procedes de production d'hydroxy-pivaldehyde
CA1022542A (en) Process for the manufacture of methylene compounds
CA1025890A (fr) Production du benzotrifluorure de phenyle
CA1023744A (fr) Procede de production de la triacetonamine
CA1014974A (en) Process for the preparation of 5-chloro-2-toluidine
CA1036169A (fr) Mode de fabrication de poly-n-alkyliminoalanes
CA1034968A (fr) Procede de preparation des alkenes
IL46242A0 (en) Process for the manufacture of beta-chloroethyl-methyl-dichlorosilane
CA1033742A (fr) Methode de preparation de derives de la quinoleine
CA1010039A (en) Process for the manufacture of s-triazinyl-monoisocyanates or s-triazinyl-diisocyanates
CA1021349A (en) Process for the manufacture of cyclopropanecarbonitrile
CA1029380A (fr) Mode de production des cyanopyridines
CA1016188A (en) Process for the manufacture of trimethylphenol
CA1026340A (fr) Procede de fabrication de nouveaux oxoalkylpyridines
CA1021345A (fr) Processus de fabrication des epoxydes
CA1010860A (en) Process for the manufacture of new anhydrofuranose derivatives
CA1029505A (fr) Procede de production du bleu de prusse
IL45261A0 (en) Process for the manufacture of 17beta-oxalylsteroids
CA1034497A (fr) Procede de preparation du choleragene
CA1028449A (fr) Procede de fabrication du polyethylene
CA1002053A (en) Process for the production of 2-cyanopyridines
CA1024166A (fr) Production de polyethers
AU479017B2 (en) Process for the manufacture of a -3-keto-steroid-17-propiolactone